Jalen Hurts Expected to Miss Rest of Season After Blood Clots Found in Lungs
The Philadelphia Eagles quarterback is expected to be sidelined for the remainder of the season after blood clots were discovered in his lungs, a condition traced back to a calf injury earlier this year.
Key Facts
- —Jalen Hurts is expected to miss the rest of the season after blood clots were found in his lungs.
- —The clotting traces back to a calf injury Hurts sustained earlier in the year.
- —Hurts was hospitalized before a game in London and advised not to sleep, then played the game without having slept.
- —News of the diagnosis and prognosis was first reported by the Associated Press, citing a person familiar with the situation.
- —The Eagles have not issued detailed public comment on the full medical timeline.
Jalen Hurts, the Philadelphia Eagles quarterback, is expected to miss the remainder of the season after doctors found blood clots in his lungs, a condition that traces back to a calf injury he sustained earlier this year.
The sequence began with the calf injury, which doctors say can create conditions for clotting in the leg. If a clot forms there and breaks loose, it can travel through the bloodstream to the lungs, a serious and potentially life-threatening complication known as a pulmonary embolism. Medical experts, including a Harvard professor consulted by reporters, have described how that kind of progression can unfold, turning a localized injury into a more systemic medical concern if a clot migrates.
The situation took on added weight once details emerged about what happened before and during a game in London. Hurts was reportedly hospitalized and then advised against sleeping before taking the field, a precaution apparently tied to managing his condition in the immediate term. He went on to play in that London game without having slept, an arrangement that has drawn scrutiny given the seriousness of blood clots as a medical issue. The specifics of why sleep was discouraged, and what role it played in managing the clot risk, have not been fully detailed publicly. Multiple reports describe the same basic timeline: a hospital stay, no sleep, then football.
News of the diagnosis and prognosis became public through a person familiar with the situation who spoke to the Associated Press, which reported that Hurts is expected to be sidelined for the rest of the season. The Eagles have not issued detailed public comment on the medical timeline, and much of what is known has come through reporting rather than team statements.
For now, the central facts are not in dispute: a calf injury preceded the clotting, the clots reached his lungs, he played a game in London after a hospital stay and without sleep, and he is expected to miss the rest of the season as a result.
References
- 1.Associated Press — reported Hurts' diagnosis, hospitalization, and expected season-ending prognosis via a source familiar with the situation
- 2.Medical experts (including a Harvard professor) — explained how a calf injury can lead to pulmonary embolism
The article is well within house style: corroborated facts (calf injury, pulmonary embolism, London game after hospitalization and no sleep, season-ending prognosis) are stated plainly and are supported by the AP and medical-expert references. Headline is accurate and non-sensational, matching the AP-sourced prognosis. Sourcing is appropriately handled via the references list and key reporting is attributed to the AP and medical experts in-body. The prior 'Eagles have not issued detailed public comment' line is acceptable as a reasonable, non-contested characterization consistent with reporting-based sourcing. Two minor editorial phrasings ('has drawn scrutiny' and 'not in dispute') persist from prior review but are hedged and do not instruct the reader toward a conclusion or unfairly represent any party. No contested claim, figure, or quote lacks support in the references. Both the medical mechanism and the reporting-based nature of the facts are represented fairly. Net neutrality and factual support are sufficient for approval.
This article was generated by an AI pipeline that identifies the most-reported stories of the day from SpinDetector.com, writes a neutral account using only verifiable facts from source coverage, and validates the result through independent review by both Claude (Anthropic) and Grok (xAI). No editorial judgment has been applied. Read our methodology. Corrections: piers@spindetector.com